Fig. 1From: Ergothioneine supplementation in people with metabolic syndrome (ErgMS): protocol for a randomised, double-blind, placebo-controlled pilot studyErgMS Study design. BMI body mass index, BP blood pressure, FFQ food frequency questionnaire, TAG triacylglyceride, HDL-C high-density lipoprotein-cholesterolBack to article page